GI-5005

BIOLOGICAL2 trials

Sponsors

GlobeImmune

Conditions

Genotype 1 Chronic Hepatitis CHepatitis C

Phase 1

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection

CompletedNCT00124215

GlobeImmuneHepatitis C

Start: 2005-06-30End: 2010-02-28Target: 48Updated: 2010-05-05

Phase 2

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection

CompletedNCT00606086

GlobeImmuneGenotype 1 Chronic Hepatitis C

Start: 2007-12-31End: 2012-11-30Updated: 2014-06-27